M.a José Alcaine Villarroya , Eva M. Barrenechea Iparraguirre , Elena Casals , Concepción González Rodríguez , Inmaculada Martín Navas , Hada Macher Manzano , M. Concepción Martínez Camarasa , Daniel Morell García , Helena Méndez Sol , Irene Rosas Allende , Elvira Tejedor Hernández , Belén Prieto García
{"title":"Utilidad de los marcadores bioquímicos de preeclampsia","authors":"M.a José Alcaine Villarroya , Eva M. Barrenechea Iparraguirre , Elena Casals , Concepción González Rodríguez , Inmaculada Martín Navas , Hada Macher Manzano , M. Concepción Martínez Camarasa , Daniel Morell García , Helena Méndez Sol , Irene Rosas Allende , Elvira Tejedor Hernández , Belén Prieto García","doi":"10.1016/j.labcli.2018.06.001","DOIUrl":null,"url":null,"abstract":"<div><p>Pre-eclampsia (PE) is one of the leading causes of maternal and perinatal mortality in the world. In developed countries, studies point to a significant increase in the incidence of PE in the last decade, partly due to the increase in the prevalence in the general population of diseases that affect vascular function, such as diabetes. chronic hypertension, or kidney disease. An updated review of PE is presented in this article. The diagnostic criteria and the pathophysiology of the disease are described. The main objective of the document is to review the new biochemical markers that may be useful in clinical practice for the prediction and diagnosis of PE, as well as the different methods by which yey can be determined.</p></div>","PeriodicalId":101105,"journal":{"name":"Revista del Laboratorio Clínico","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.labcli.2018.06.001","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista del Laboratorio Clínico","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1888400818300485","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Pre-eclampsia (PE) is one of the leading causes of maternal and perinatal mortality in the world. In developed countries, studies point to a significant increase in the incidence of PE in the last decade, partly due to the increase in the prevalence in the general population of diseases that affect vascular function, such as diabetes. chronic hypertension, or kidney disease. An updated review of PE is presented in this article. The diagnostic criteria and the pathophysiology of the disease are described. The main objective of the document is to review the new biochemical markers that may be useful in clinical practice for the prediction and diagnosis of PE, as well as the different methods by which yey can be determined.